Insider · CIK 0001197355

FUCHS HENRY J

Reports to the SEC for 5 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001197355

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-13	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−12.1K sh	$84.90	−$1.03M	185,074
2024-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+300 sh	$68.65	+$20.6K	197,172
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)A Award	President, Worldwide R&D	AAward	+40.9K sh	—	—	40,860
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+18.2K sh	—	—	230,357
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−33.5K sh	$83.87	−$2.81M	196,872
2024-03-05	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	President, Worldwide R&D	SSale	−35.3K sh	$85.18	−$3.01M	212,117
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+13.3K sh	—	—	238,220
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+9,238 sh	—	—	247,458
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+30.6K sh	—	—	224,894
2023-12-01	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+17.8K sh	—	—	194,254
2023-08-10	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	President, Worldwide R&D	SSale	−12K sh	$90.43	−$1.09M	176,187
2023-04-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+317 sh	$66.88	+$21.2K	176,504
2023-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−36K sh	$93.41	−$3.36M	188,187
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	President, Worldwide R&D	AAward	+38.5K sh	—	—	38,450
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−4,799 sh	$87.74	−$421K	224,187
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+16.8K sh	—	—	228,986
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+13.4K sh	—	—	212,146
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+18.2K sh	—	—	198,754
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+36.4K sh	—	—	180,534
2023-01-20	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+7,520 sh	—	—	7,520
2023-01-20	Mirati Therapeutics, Inc.A Award	Director	AAward	+4,444 sh	—	—	10,465
2022-04-29	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+341 sh	$62.41	+$21.3K	144,094
2022-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−2,259 sh	$80.72	−$182K	143,753
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+38.8K sh	—	—	158,113
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−12.1K sh	$78.27	−$947K	146,012
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	President, Worldwide R&D	AAward	+35.8K sh	—	—	35,830
2022-03-08	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+12.8K sh	—	—	119,323
2022-02-11	Mirati Therapeutics, Inc.S Sale	Director	SSale	−210 sh	$106.34	−$22.3K	6,021
2022-02-11	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2022-02-11	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2022-02-11	Mirati Therapeutics, Inc.S Sale	Director	SSale	−8,700 sh	$105.80	−$920K	6,231
2022-02-11	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$20.54	+$103K	17,021
2022-02-11	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$20.54	+$123K	12,021
2022-02-11	Mirati Therapeutics, Inc.S Sale	Director	SSale	−2,090 sh	$104.76	−$219K	14,931
2022-01-14	Mirati Therapeutics, Inc.A Award	Director	AAward	+2,546 sh	—	—	6,021
2022-01-14	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+3,688 sh	—	—	3,688
2021-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+341 sh	$62.41	+$21.3K	106,483
2021-03-22	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−2,454 sh	$78.52	−$193K	106,142
2021-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−2,259 sh	$77.21	−$174K	108,596
2021-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	President, Worldwide R&D	AAward	+37.7K sh	—	—	37,710
2021-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	President, Worldwide R&D	AAward	+15.3K sh	—	—	118,315
2021-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	President, Worldwide R&D	FTax Payment	−7,460 sh	$78.39	−$585K	110,855
2021-01-15	Mirati Therapeutics, Inc.A Award	Director	AAward	+1,475 sh	—	—	3,475
2021-01-15	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+2,155 sh	—	—	2,155
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,218 sh	$230.19	−$280K	10,782
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,399 sh	$232.01	−$325K	9,383
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−610 sh	$234.27	−$143K	4,312
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,821 sh	$235.19	−$428K	2,491
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−4,461 sh	$233.40	−$1.04M	4,922
2020-12-15	Mirati Therapeutics, Inc.S Sale	Director	SSale	−451 sh	$237.36	−$107K	2,040

Recent filings

Accepted (ET)
Sep 174
FUCHS HENRY J0001048477-24-000141
SEC(opens sec.gov)
Mar 194
FUCHS HENRY J0001048477-24-000042
SEC(opens sec.gov)
Mar 74
FUCHS HENRY J0001048477-24-000034
SEC(opens sec.gov)
Feb 294
FUCHS HENRY J0001048477-24-000020
SEC(opens sec.gov)
Dec 54
FUCHS HENRY J0001048477-23-000049
SEC(opens sec.gov)
Aug 114
FUCHS HENRY J0001048477-23-000037
SEC(opens sec.gov)
Mar 174
FUCHS HENRY J0001567619-23-005295
SEC(opens sec.gov)
Mar 24
FUCHS HENRY J0001209191-23-014606
SEC(opens sec.gov)
Feb 105
FUCHS HENRY J0001567619-23-002420
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE

NOVATO, CA, 94949